Have a personal or library account? Click to login
Efficacy of gefitinib and radiotherapy combination in Indonesian patients with lung adenocarcinoma Cover

Efficacy of gefitinib and radiotherapy combination in Indonesian patients with lung adenocarcinoma

Open Access
|Aug 2018

Authors

Elisna Syahruddin

Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia

Aida Lufti Huswatun

Department of Radiotherapy, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia

Ari Prabowo

Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia

Jamal Zaini

Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia

Fariz Nurwidya

fariz.nurwidya@gmail.com

Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia

Achmad Hudoyo

Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia

Anwar Jusuf

Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia
DOI: https://doi.org/10.2478/rjim-2018-0011 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 173 - 181
Submitted on: Jan 29, 2018
Published on: Aug 29, 2018
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2018 Elisna Syahruddin, Aida Lufti Huswatun, Ari Prabowo, Jamal Zaini, Fariz Nurwidya, Achmad Hudoyo, Anwar Jusuf, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.